<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" generatedBy="WIX">
<url>
<loc>https://www.liverconnect.org/2024-lc-webcasts-1/hdv-case-and-panel-discussion-</loc>
<lastmod>2024-07-18</lastmod>
</url>
<url>
<loc>https://www.liverconnect.org/2024-lc-webcasts-1/hbv-case-and-panel-discussion</loc>
<lastmod>2024-07-18</lastmod>
</url>
<url>
<loc>https://www.liverconnect.org/2024-lc-webcasts-1/navigating-challenges-in-hcv-therapy%3A-addressing-the-issues-that-remain</loc>
<lastmod>2024-07-18</lastmod>
</url>
<url>
<loc>https://www.liverconnect.org/2024-lc-webcasts-1/diagnosis-and-management-of-hepatitis-e</loc>
<lastmod>2024-07-18</lastmod>
</url>
<url>
<loc>https://www.liverconnect.org/2024-lc-webcasts-1/q%26a%2Fpanel-discussion-</loc>
<lastmod>2024-06-28</lastmod>
</url>
<url>
<loc>https://www.liverconnect.org/2024-lc-webcasts-1/psc-update-and-cholestatic-itch-</loc>
<lastmod>2024-06-28</lastmod>
</url>
<url>
<loc>https://www.liverconnect.org/2024-lc-webcasts-1/debate%3A-what-should-be-used-as-the-first-line-treatment-for-autoimmune-hepatitis-(aih)%3F</loc>
<lastmod>2024-06-28</lastmod>
</url>
<url>
<loc>https://www.liverconnect.org/2024-lc-webcasts-1/navigating-the-future%3A-emerging-therapies-and-strategic-positioning-in-the-management-of-primary-biliary-cholangitis-(pbc)</loc>
<lastmod>2024-06-28</lastmod>
</url>
<url>
<loc>https://www.liverconnect.org/2024-lc-webcasts-1/mock-tumor-board-case-2%3A-selecting-the-best-treatment-for-inoperable-hcc</loc>
<lastmod>2024-06-28</lastmod>
</url>
<url>
<loc>https://www.liverconnect.org/2024-lc-webcasts-1/mock-tumor-board-case-1%3A-weighing-the-options-of-surgery-vs.-transplant</loc>
<lastmod>2024-06-28</lastmod>
</url>
<url>
<loc>https://www.liverconnect.org/2024-lc-webcasts-1/what&apos;s-in-and-what&apos;s-out%3A-highlights-and-takeaways-from-updated-aasld-hcc--practice-guidelines</loc>
<lastmod>2024-06-28</lastmod>
</url>
<url>
<loc>https://www.liverconnect.org/2024-lc-webcasts-1/drug-treatment-for-mash-in-2024</loc>
<lastmod>2024-06-28</lastmod>
</url>
<url>
<loc>https://www.liverconnect.org/2024-lc-webcasts-1/lifestyle-recommendations-in-clinical-practice-</loc>
<lastmod>2024-06-28</lastmod>
</url>
<url>
<loc>https://www.liverconnect.org/2024-lc-webcasts-1/role-of-non-hepatologists-in-the-management-of-patients-with-nash%2Fmasld</loc>
<lastmod>2024-06-28</lastmod>
</url>
<url>
<loc>https://www.liverconnect.org/2024-lc-webcasts-1/use-of-surrogate-markers-and-algorithms-to-identify-high-risk-patients-and-optimize-outcomes</loc>
<lastmod>2024-06-28</lastmod>
</url>
<url>
<loc>https://www.liverconnect.org/2024-lc-webcasts-1/the-continuum-of-disease%3A-rethinking-the-existing-categories-and-stages</loc>
<lastmod>2024-06-28</lastmod>
</url>
<url>
<loc>https://www.liverconnect.org/2024-lc-webcasts-1/case-iii%3A-surgical-risk-stratification</loc>
<lastmod>2024-06-28</lastmod>
</url>
<url>
<loc>https://www.liverconnect.org/2024-lc-webcasts-1/case-ii%3A-refractory-he</loc>
<lastmod>2024-06-28</lastmod>
</url>
<url>
<loc>https://www.liverconnect.org/2024-lc-webcasts-1/case-i%3A-obese-patient-with-nash-cirrhosis-</loc>
<lastmod>2024-06-28</lastmod>
</url>
<url>
<loc>https://www.liverconnect.org/2024-lc-webcasts-1/liver-transplantation%3A-more-than-surgery</loc>
<lastmod>2024-06-28</lastmod>
</url>
<url>
<loc>https://www.liverconnect.org/2024-lc-webcasts-1/management-of-alcohol-associated-hepatitis-</loc>
<lastmod>2024-06-28</lastmod>
</url>
<url>
<loc>https://www.liverconnect.org/2024-lc-webcasts-1/willis-c.-maddrey-distinguished-lecture-on-alcohol-liver-</loc>
<lastmod>2024-06-28</lastmod>
</url>
</urlset>